[Form 4] Silicon Laboratories Inc Insider Trading Activity
Brandon Tolany, Senior Vice President Worldwide Sales & Marketing of Silicon Laboratories Inc. (SLAB), reported insider transactions dated 08/29/2025. The filing shows the exercise of a non-qualified stock option with a $43.82 exercise price that resulted in acquisition of 1,800 common shares, and a contemporaneous disposition of 1,800 common shares sold at $133.57. After the reported non-derivative transactions the filing lists beneficial ownership amounts of 64,128 and 62,328 shares following each reported non-derivative line, and Table II reports 6,200 derivative securities beneficially owned following the option transactions. The form is filed individually and signed on behalf of the reporting person.
Brandon Tolany, Senior Vice President Worldwide Sales & Marketing di Silicon Laboratories Inc. (SLAB), ha segnalato operazioni insider datate 29/08/2025. La comunicazione indica l'esercizio di un'opzione non qualificata con prezzo di esercizio di $43,82 che ha comportato l'acquisizione di 1.800 azioni ordinarie e la contestuale cessione di 1.800 azioni ordinarie vendute a $133,57. Dopo le operazioni non derivative riportate, la dichiarazione indica una partecipazione beneficiaria di 64.128 e 62.328 azioni rispettivamente dopo ciascuna riga non derivata segnalata, e la Tabella II riporta 6.200 strumenti derivati di cui 猫 beneficiario a seguito delle operazioni sull'opzione. Il modulo 猫 depositato a titolo individuale e firmato per conto del dichiarante.
Brandon Tolany, Senior Vice President Worldwide Sales & Marketing de Silicon Laboratories Inc. (SLAB), inform贸 operaciones internas con fecha 29/08/2025. La presentaci贸n muestra el ejercicio de una opci贸n sobre acciones no calificada con precio de ejercicio de $43,82 que result贸 en la adquisici贸n de 1.800 acciones ordinarias y la disposici贸n simult谩nea de 1.800 acciones ordinarias vendidas a $133,57. Tras las transacciones no derivadas reportadas, el formulario enumera participaciones beneficiarias de 64.128 y 62.328 acciones despu茅s de cada l铆nea no derivada informada, y la Tabla II registra 6.200 instrumentos derivados de los que es beneficiario tras las operaciones de la opci贸n. El formulario se presenta a t铆tulo individual y est谩 firmado en nombre de la persona informante.
敫岆灉霌� 韱澕雼�(Brandon Tolany), Silicon Laboratories Inc.(SLAB) 鞝� 靹戈硠 鞓侅梾路毵堨紑韺� 靾橃劃攵�靷灔鞚� 2025雲� 8鞗� 29鞚检瀽 雮措秬鞛� 瓯半灅毳� 鞁犼碃頄堨姷雼堧嫟. 鞝滌稖靹滊鞐愲姅 頄夓偓臧�瓴� $43.82鞚� 牍勳瀽瓴� 鞀ろ啞鞓奠厴鞚� 頄夓偓頃橃棳 1,800欤� 氤错喌欤茧ゼ 旆摑頃橁碃, 霃欖嫓鞐� 1,800欤茧ゼ 欤茧嫻 $133.57鞐� 觳橂秳頃� 雮挫棴鞚� 旮办灛霅橃柎 鞛堨姷雼堧嫟. 氤搓碃霅� 牍勴寣靸� 瓯半灅 鞚错泟 鞝滌稖靹滊鞐愲姅 臧� 牍勴寣靸� 頃氤勲 臧侁皝 64,128欤检檧 62,328欤检潣 鞁れ鞝� 靻岇湢歆�攵勳澊 旮办灛霅橃柎 鞛堨溂氅�, 響� II鞐愲姅 頃措嫻 鞓奠厴 瓯半灅 鞚错泟鞐� 鞁れ鞝侅溂搿� 氤挫湢頃� 6,200臧滌潣 韺岇儩歃濌秾鞚� 氤搓碃霅橃柎 鞛堨姷雼堧嫟. 頃措嫻 靹滌嫕鞚� 臧滌澑 氇呾潣搿� 鞝滌稖霅橃棃瓿� 氤搓碃鞛� 氇呾潣搿� 靹滊獏霅橃棃鞀惦媹雼�.
Brandon Tolany, Senior Vice President Worldwide Sales & Marketing de Silicon Laboratories Inc. (SLAB), a d茅clar茅 des op茅rations d'initi茅s dat茅es du 29/08/2025. Le dossier indique l'exercice d'une option non qualifi茅e au prix d'exercice de 43,82 $ ayant entra卯n茅 l'acquisition de 1 800 actions ordinaires et la cession concomitante de 1 800 actions ordinaires vendues 脿 133,57 $. Apr猫s les op茅rations non d茅riv茅es d茅clar茅es, le formulaire fait 茅tat de d茅tentions b茅n茅ficiaires de 64 128 et 62 328 actions respectivement apr猫s chaque ligne non d茅riv茅e rapport茅e, et le Tableau II signale 6 200 instruments d茅riv茅s dont il est b茅n茅ficiaire 脿 la suite des op茅rations sur option. Le formulaire est d茅pos茅 脿 titre individuel et sign茅 au nom de la personne d茅clarante.
Brandon Tolany, Senior Vice President Worldwide Sales & Marketing von Silicon Laboratories Inc. (SLAB), meldete Insider-Transaktionen vom 29.08.2025. Die Einreichung weist die Aus眉bung einer nicht qualifizierten Optionsvereinbarung mit einem Aus眉bungspreis von $43,82 aus, die zum Erwerb von 1.800 Stammaktien f眉hrte, sowie die gleichzeitige Ver盲u脽erung von 1.800 Stammaktien zu je $133,57. Nach den gemeldeten nicht-derivativen Transaktionen werden im Formular Nutzungsbest盲nde von 64.128 bzw. 62.328 Aktien nach den jeweiligen nicht-derivativen Zeilen aufgef眉hrt, und Tabelle II meldet 6.200 derivativen Wertpapiere, die infolge der Optionsgesch盲fte wirtschaftlich gehalten werden. Das Formular wurde individuell eingereicht und im Namen der meldenden Person unterzeichnet.
- Transparent disclosure of option exercise and share sale with transaction prices and post-transaction ownership counts
- Form filed individually and includes signature and reporting person role (Sr VP WW Sales & Marketing)
- Sale of 1,800 shares at $133.57 reduced reported non-derivative holdings as shown in the filing
- No additional context provided on purpose of sale or use of proceeds in the filing
Insights
TL;DR: Officer exercised options and sold an equal number of shares on 08/29/2025; transactions appear routine and non-dilutive to current shareholders.
The filing documents a non-qualified option exercise at an exercise price of $43.82 for 1,800 shares and a same-day sale of 1,800 shares at $133.57. Reported beneficial ownership figures are provided on separate lines: 64,128 and 62,328 shares after the non-derivative transactions, and 6,200 derivative securities outstanding following the option activity. These are factual disclosures of personal transactions by an officer and do not include company forecasts, material corporate events, or changes to capital structure beyond the individual exercises and sale.
TL;DR: Disclosure meets Section 16 reporting requirements for an officer; shows option exercise and sale with detailed post-transaction ownership figures.
The Form 4 identifies the reporting person as an officer (Sr VP WW Sales & Marketing) and indicates the form was filed by one reporting person. It lists transaction codes and prices, including an exercise-related acquisition and a sale at market, and provides resulting beneficial ownership counts. The filing includes a signature date and the required instructional remarks, consistent with routine insider reporting practices under the Exchange Act.
Brandon Tolany, Senior Vice President Worldwide Sales & Marketing di Silicon Laboratories Inc. (SLAB), ha segnalato operazioni insider datate 29/08/2025. La comunicazione indica l'esercizio di un'opzione non qualificata con prezzo di esercizio di $43,82 che ha comportato l'acquisizione di 1.800 azioni ordinarie e la contestuale cessione di 1.800 azioni ordinarie vendute a $133,57. Dopo le operazioni non derivative riportate, la dichiarazione indica una partecipazione beneficiaria di 64.128 e 62.328 azioni rispettivamente dopo ciascuna riga non derivata segnalata, e la Tabella II riporta 6.200 strumenti derivati di cui 猫 beneficiario a seguito delle operazioni sull'opzione. Il modulo 猫 depositato a titolo individuale e firmato per conto del dichiarante.
Brandon Tolany, Senior Vice President Worldwide Sales & Marketing de Silicon Laboratories Inc. (SLAB), inform贸 operaciones internas con fecha 29/08/2025. La presentaci贸n muestra el ejercicio de una opci贸n sobre acciones no calificada con precio de ejercicio de $43,82 que result贸 en la adquisici贸n de 1.800 acciones ordinarias y la disposici贸n simult谩nea de 1.800 acciones ordinarias vendidas a $133,57. Tras las transacciones no derivadas reportadas, el formulario enumera participaciones beneficiarias de 64.128 y 62.328 acciones despu茅s de cada l铆nea no derivada informada, y la Tabla II registra 6.200 instrumentos derivados de los que es beneficiario tras las operaciones de la opci贸n. El formulario se presenta a t铆tulo individual y est谩 firmado en nombre de la persona informante.
敫岆灉霌� 韱澕雼�(Brandon Tolany), Silicon Laboratories Inc.(SLAB) 鞝� 靹戈硠 鞓侅梾路毵堨紑韺� 靾橃劃攵�靷灔鞚� 2025雲� 8鞗� 29鞚检瀽 雮措秬鞛� 瓯半灅毳� 鞁犼碃頄堨姷雼堧嫟. 鞝滌稖靹滊鞐愲姅 頄夓偓臧�瓴� $43.82鞚� 牍勳瀽瓴� 鞀ろ啞鞓奠厴鞚� 頄夓偓頃橃棳 1,800欤� 氤错喌欤茧ゼ 旆摑頃橁碃, 霃欖嫓鞐� 1,800欤茧ゼ 欤茧嫻 $133.57鞐� 觳橂秳頃� 雮挫棴鞚� 旮办灛霅橃柎 鞛堨姷雼堧嫟. 氤搓碃霅� 牍勴寣靸� 瓯半灅 鞚错泟 鞝滌稖靹滊鞐愲姅 臧� 牍勴寣靸� 頃氤勲 臧侁皝 64,128欤检檧 62,328欤检潣 鞁れ鞝� 靻岇湢歆�攵勳澊 旮办灛霅橃柎 鞛堨溂氅�, 響� II鞐愲姅 頃措嫻 鞓奠厴 瓯半灅 鞚错泟鞐� 鞁れ鞝侅溂搿� 氤挫湢頃� 6,200臧滌潣 韺岇儩歃濌秾鞚� 氤搓碃霅橃柎 鞛堨姷雼堧嫟. 頃措嫻 靹滌嫕鞚� 臧滌澑 氇呾潣搿� 鞝滌稖霅橃棃瓿� 氤搓碃鞛� 氇呾潣搿� 靹滊獏霅橃棃鞀惦媹雼�.
Brandon Tolany, Senior Vice President Worldwide Sales & Marketing de Silicon Laboratories Inc. (SLAB), a d茅clar茅 des op茅rations d'initi茅s dat茅es du 29/08/2025. Le dossier indique l'exercice d'une option non qualifi茅e au prix d'exercice de 43,82 $ ayant entra卯n茅 l'acquisition de 1 800 actions ordinaires et la cession concomitante de 1 800 actions ordinaires vendues 脿 133,57 $. Apr猫s les op茅rations non d茅riv茅es d茅clar茅es, le formulaire fait 茅tat de d茅tentions b茅n茅ficiaires de 64 128 et 62 328 actions respectivement apr猫s chaque ligne non d茅riv茅e rapport茅e, et le Tableau II signale 6 200 instruments d茅riv茅s dont il est b茅n茅ficiaire 脿 la suite des op茅rations sur option. Le formulaire est d茅pos茅 脿 titre individuel et sign茅 au nom de la personne d茅clarante.
Brandon Tolany, Senior Vice President Worldwide Sales & Marketing von Silicon Laboratories Inc. (SLAB), meldete Insider-Transaktionen vom 29.08.2025. Die Einreichung weist die Aus眉bung einer nicht qualifizierten Optionsvereinbarung mit einem Aus眉bungspreis von $43,82 aus, die zum Erwerb von 1.800 Stammaktien f眉hrte, sowie die gleichzeitige Ver盲u脽erung von 1.800 Stammaktien zu je $133,57. Nach den gemeldeten nicht-derivativen Transaktionen werden im Formular Nutzungsbest盲nde von 64.128 bzw. 62.328 Aktien nach den jeweiligen nicht-derivativen Zeilen aufgef眉hrt, und Tabelle II meldet 6.200 derivativen Wertpapiere, die infolge der Optionsgesch盲fte wirtschaftlich gehalten werden. Das Formular wurde individuell eingereicht und im Namen der meldenden Person unterzeichnet.
FAQ
What transactions did SLAB officer Brandon Tolany report on the Form 4?
How many shares does Brandon Tolany beneficially own after the reported transactions?
What was the exercise price and sale price reported on the Form 4 for SLAB?
What is Brandon Tolany's role at Silicon Laboratories as stated on the Form 4?
When was the Form 4 transaction dated and when was the form signed?
